Efficacy and safety of intralesional vitamin D3 injection in wart
Libyan Journal of Medical Research · 02.05.2026 · 20 (2) · 224-232
DOI: 10.54361/ljmr.20.2.36 ↗Kurz gefasst
Fachartikel in der Zeitschrift Libyan Journal of Medical Research, online erschienen am 02.05.2026. Verfasst von Hana Benjuma. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Verrucae, or warts, are the benign proliferations of mucosa and skin. They present over the hands in most patients but can occur anywhere on the surface of the skin or the mucosa.
Aim
To investigate both the safety and effectiveness of intralesional cholecalciferol (vitamin D3) in the management of warts.Materials and Methods: This observational study included 40 patients with cutaneous warts, conducted from April 2023 to April 2024 at the Alirada clinic. After administering lignocaine (0.2 mL, 20 mg/mL), vitamin D3 (0.2 mL, 15 mg/mL) was injected into the base of the warts. Injections were repeated every two weeks for a maximum of four sessions or until complete resolution Results: The mean age was 30.85 ± 12.51 years, with a mean wart duration of 15.75 ± 12.15 months and an average of 7.8 ± 6.7 warts per patient. The group comprised 45% males and 55% females. Wart types included: filiform (5%), palmoplantar (70%), plane (10%), and verruca vulgaris (15%). Complete resolution occurred in 65% of cases, moderate response in 15%, mild response in 15%, and no response in 5%. At baseline, 10 patients (25%) reported pain due to the warts, primarily in palmoplantar warts, with 90% resolution within 14 days of treatment. After treatment, post-injection pain occurred in 12 patients (30%), mostly transient and resolving within 3–5 days. Other side effects included swelling (20%), nodule formation (7.5%), and pigmentary changes (hyper- or hypo-) (2.5%), with no hypopigmentation reported. Treatment response was positively correlated with gender and verruca vulgaris but negatively correlated with plane wartsConclusion: Intralesional vitamin D3 treatment is simple, effective, affordable, safe, and easy to administer in outpatient clinics. However, small sample sizes limit generalizability for certain wart types.
Zitieren
APA
Benjuma, H. (2026). Efficacy and safety of intralesional vitamin D3 injection in wart. Libyan Journal of Medical Research, 20(2), 224-232. https://doi.org/10.54361/ljmr.20.2.36
Vancouver
Benjuma H. Efficacy and safety of intralesional vitamin D3 injection in wart. Libyan Journal of Medical Research. 2026;20(2):224-232. doi:10.54361/ljmr.20.2.36
BibTeX
@article{Benjuma2026,
author = {Benjuma, Hana},
title = {Efficacy and safety of intralesional vitamin D3 injection in wart},
journal = {Libyan Journal of Medical Research},
year = {2026},
volume = {20},
number = {2},
pages = {224--232},
doi = {10.54361/ljmr.20.2.36}
}
EUVIMED